United States · FDA National Drug Code directory
METOLAZONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81005-126_4575818c-096e-64e5-e063-6294a90ad3b7
- Product NDC
- 81005-126
- Form
- TABLET
- Composition / generic term
- metolazone
- Labeler
- Aarkish Pharmaceuticals NJ Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230815
- Source listing expiry
- 20261231
Source-listed ingredients
- METOLAZONE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (81005-126-01) · 81005-126-01
- 1000 TABLET in 1 BOTTLE (81005-126-10) · 81005-126-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →